Navamedic ASA (OSL:NAVA)

Navamedic ASA Ratios and Metrics

Market cap in millions NOK. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 2, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	373	454	637	601	556	292
Market Cap Growth	-28.72%	-28.72%	5.92%	8.19%	90.28%	33.03%
Enterprise Value	454	534	720	625	561	288
Last Close Price	21.10	25.70	36.70	34.90	34.00	19.10
PE Ratio	288.90	351.89	192.75	20.43	899.28	-
PS Ratio	0.85	0.85	1.24	1.57	2.00	1.39
PB Ratio	1.89	1.89	2.86	2.87	3.68	2.26
P/TBV Ratio	-	-	-	7.67	8.84	5.28
P/FCF Ratio	11.83	11.83	-	38.32	-	-
P/OCF Ratio	11.83	11.83	292.27	33.51	-	-
EV/Sales Ratio	0.85	1.01	1.41	1.64	2.02	1.37
EV/EBITDA Ratio	9.75	11.48	14.65	12.60	34.77	-
EV/EBIT Ratio	14.28	16.81	18.17	14.07	49.01	-
EV/FCF Ratio	13.93	13.93	-	39.84	-	-
Debt / Equity Ratio	0.49	0.49	0.69	0.28	0.31	0.18
Debt / EBITDA Ratio	2.55	2.55	2.96	1.14	2.57	-
Debt / FCF Ratio	3.09	3.09	-	3.74	-	-
Asset Turnover	1.05	1.05	1.13	1.07	0.94	0.94
Inventory Turnover	3.45	3.45	3.39	3.09	3.21	3.78
Quick Ratio	0.72	0.72	0.55	0.90	0.78	0.72
Current Ratio	1.42	1.42	1.11	1.93	1.51	1.12
Return on Equity (ROE)	0.56%	0.56%	1.53%	16.31%	0.44%	-15.77%
Return on Assets (ROA)	3.91%	3.91%	5.46%	7.79%	2.43%	-1.38%
Return on Capital (ROIC)	5.41%	5.41%	7.70%	11.91%	4.09%	-2.40%
Return on Capital Employed (ROCE)	9.10%	9.10%	11.80%	17.30%	5.90%	-
Earnings Yield	0.35%	0.28%	0.52%	4.90%	0.11%	-5.64%
FCF Yield	8.45%	8.45%	-0.00%	2.61%	-0.36%	-1.15%
Buyback Yield / Dilution	-	-3.47%	-3.60%	-13.61%	-23.54%

Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.